Caroline Loew
Nessuna posizione attualmente
Patrimonio netto: 849 818 $ in data 31/05/2024
Profilo
Caroline J.
Loew is currently the President, Chief Executive Officer & Director at Mural Oncology Plc.
Previously, she held the position of President, Chief Executive Officer & Director at Glympse Bio, Inc. from 2018 to 2022, and Vice President & Head-Research at Bristol-Myers Squibb Co. from 2015 to 2018.
Dr. Loew obtained her undergraduate and doctorate degrees from Imperial College London.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
1.49% | 01/03/2024 | 252 922 ( 1.49% ) | 849 818 $ | 31/05/2024 |
Posizioni attive di Caroline Loew
Società | Posizione | Inizio |
---|
Precedenti posizioni note di Caroline Loew
Società | Posizione | Fine |
---|---|---|
Glympse Bio, Inc.
Glympse Bio, Inc. BiotechnologyHealth Technology Glympse Bio, Inc. develops modular nanoparticle sensors to create diagnostics for diseases. It uses engineered diagnostic agents that interrogate the body for certain disease states, and then carry the message to the urine for analysis. The company was founded in 2015 by Sangeeta Bhatia and Gabe A. Kwong and is headquartered in Cambridge, MA. | Amministratore Delegato | 01/08/2022 |
Formazione di Caroline Loew
Imperial College London | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
Glympse Bio, Inc.
Glympse Bio, Inc. BiotechnologyHealth Technology Glympse Bio, Inc. develops modular nanoparticle sensors to create diagnostics for diseases. It uses engineered diagnostic agents that interrogate the body for certain disease states, and then carry the message to the urine for analysis. The company was founded in 2015 by Sangeeta Bhatia and Gabe A. Kwong and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Caroline Loew